Comment
doi: 10.2337/dci16-0035.
DPP-4 Inhibitor-Related Pancreatitis: Rare but Real!
Affiliations
- PMID: 28108536
- DOI: 10.2337/dci16-0035
Item in Clipboard
Comment
DPP-4 Inhibitor-Related Pancreatitis: Rare but Real!
Diabetes Care.
2017 Feb.
No abstract available
Comment on
-
Pancreatic Safety of Sitagliptin in the TECOS Study.Diabetes Care. 2017 Feb;40(2):164-170. doi: 10.2337/dc15-2780. Epub 2016 Sep 14. Diabetes Care. 2017. PMID: 27630212 Free PMC article. Clinical Trial.
-
Combined Analysis of Three Large Interventional Trials With Gliptins Indicates Increased Incidence of Acute Pancreatitis in Patients With Type 2 Diabetes.Diabetes Care. 2017 Feb;40(2):284-286. doi: 10.2337/dc15-1707. Epub 2016 Sep 22. Diabetes Care. 2017. PMID: 27659407 Review.
Similar articles
-
Acute pancreatitis with dipeptidyl peptidase-4 (DPP4) inhibitor or fulminant type 1 diabetes?Diabetes Metab. 2018 Feb;44(1):95-96. doi: 10.1016/j.diabet.2017.03.010. Epub 2017 May 5. Diabetes Metab. 2018. PMID: 28483292 No abstract available.
-
Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.Eur J Med Chem. 2018 May 10;151:145-157. doi: 10.1016/j.ejmech.2018.03.041. Epub 2018 Mar 21. Eur J Med Chem. 2018. PMID: 29609120 Review.
-
Synthetic and phytocompounds based dipeptidyl peptidase-IV (DPP-IV) inhibitors for therapeutics of diabetes.J Asian Nat Prod Res. 2017 Oct;19(10):1036-1045. doi: 10.1080/10286020.2017.1307183. Epub 2017 Mar 29. J Asian Nat Prod Res. 2017. PMID: 28351157 Review.
-
Incretin-based agents in type 2 diabetic patients at cardiovascular risk: compare the effect of GLP-1 agonists and DPP-4 inhibitors on cardiovascular and pancreatic outcomes.Cardiovasc Diabetol. 2017 Mar 1;16(1):31. doi: 10.1186/s12933-017-0512-z. Cardiovasc Diabetol. 2017. PMID: 28249585 Free PMC article.
-
RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes.Eur J Pharmacol. 2011 Feb 10;652(1-3):157-63. doi: 10.1016/j.ejphar.2010.06.001. Epub 2010 Jun 9. Eur J Pharmacol. 2011. PMID: 20540938
Cited by
-
Drosophila as a Rapid Screening Model to Evaluate the Hypoglycemic Effects of Dipeptidyl Peptidase 4 (DPP4) Inhibitors: High Evolutionary Conservation of DPP4.Biomedicines. 2023 Nov 12;11(11):3032. doi: 10.3390/biomedicines11113032. Biomedicines. 2023. PMID: 38002032 Free PMC article.
-
Mild Pancreatitis Induced by Linagliptin Revealed by a Medication Review.Cureus. 2023 Mar 21;15(3):e36455. doi: 10.7759/cureus.36455. eCollection 2023 Mar. Cureus. 2023. PMID: 37090411 Free PMC article.
-
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.Endocr Pract. 2022 Oct;28(10):923-1049. doi: 10.1016/j.eprac.2022.08.002. Epub 2022 Aug 11. Endocr Pract. 2022. PMID: 35963508 Free PMC article.
-
Physiological and pharmacological actions of glucagon like peptide-1 (GLP-1) in domestic animals.Vet Anim Sci. 2022 Mar 23;16:100245. doi: 10.1016/j.vas.2022.100245. eCollection 2022 Jun. Vet Anim Sci. 2022. PMID: 35372707 Free PMC article.
-
Role of dipeptidyl peptidase 4 inhibitors in the new era of antidiabetic treatment.World J Diabetes. 2022 Feb 15;13(2):85-96. doi: 10.4239/wjd.v13.i2.85. World J Diabetes. 2022. PMID: 35211246 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
